
Serina Therapeutics, Inc.
Serina Therapeutics, Inc.(SER)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · SER · 截至 2026年6月9日
活动摘要
买入笔数
3
P-Purchase only
卖出笔数
40
近12个月
买卖比
0.08
Buy/Sell (by trades)
整体情绪
Serina Therapeutics, Inc.内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
SER 季度内部人买卖趋势
SER 内幕交易卖出 · SER 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · SER CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
SER 高管卖出股份 · SER 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 26, 2026 | LEDGER STEVEN A CEO · Director | Award | 10,100 | $19K | Form 4 |
| May 22, 2026 | WILSON KAREN J Director | Purchase | 10,000 | $19K | Form 4 |
| May 21, 2026 | WILSON KAREN J Director | Purchase | 10,000 | $18K | Form 4 |
| May 19, 2026 | Marshall Richard Peter Director | Purchase | 12,183 | $20K | Form 4 |
| Mar 31, 2026 | Bailey Gregory Director | Award | 59,667 | $116K | Form 4 |
| Mar 31, 2026 | Venkatesan Jay Director | Award | 7,553 | $15K | Form 4 |
| Mar 23, 2026 | Moreadith Randall Chief Scientific Officer | Option | 6,500 | $390 | Form 4 |
| Mar 23, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 6,500 | $19K | Form 4 |
| Mar 19, 2026 | Moreadith Randall Chief Scientific Officer | Option | 39,000 | $2K | Form 4 |
| Mar 19, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 39,000 | $98K | Form 4 |
| Feb 2, 2026 | Moreadith Randall Chief Scientific Officer | Option | 6,500 | $390 | Form 4 |
| Feb 2, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 6,500 | $20K | Form 4 |
| Jan 28, 2026 | Moreadith Randall Chief Scientific Officer | Option | 6,500 | $390 | Form 4 |
| Jan 28, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 6,500 | $23K | Form 4 |
| Jan 22, 2026 | Moreadith Randall Chief Scientific Officer | Option | 2,500 | $150 | Form 4 |
| Jan 22, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 2,500 | $7K | Form 4 |
| Jan 21, 2026 | Moreadith Randall Chief Scientific Officer | Option | 2,000 | $120 | Form 4 |
| Jan 20, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 2,000 | $6K | Form 4 |
| Jan 21, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 2,000 | $6K | Form 4 |
| Jan 13, 2026 | Moreadith Randall Chief Scientific Officer | Option | 5,416 | $325 | Form 4 |
| Jan 14, 2026 | Moreadith Randall Chief Scientific Officer | Option | 1,084 | $65 | Form 4 |
| Jan 14, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 1,084 | $3K | Form 4 |
| Jan 13, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 5,416 | $14K | Form 4 |
| Jan 8, 2026 | Moreadith Randall Chief Scientific Officer | Option | 13,000 | $780 | Form 4 |
| Jan 8, 2026 | Moreadith Randall Chief Scientific Officer | Sale | 13,000 | $35K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 SER 内幕交易
SER 内幕交易
Serina Therapeutics, Inc.(SER)内幕交易数据来源于公司内部人(包括Moreadith Randall (Chief Scientific Officer), WILSON KAREN J (Director), LEDGER STEVEN A (CEO · Director))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。SER内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Serina Therapeutics, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
SER 内幕交易 · 5个问题Serina Therapeutics, Inc.(SER)的内部人包括高管和董事,如Moreadith Randall (Chief Scientific Officer), WILSON KAREN J (Director), LEDGER STEVEN A (CEO · Director)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026